and any additional information that may be perti-
nent in the future; 
(6) develop a public education and patient en-
gagement program about the safety and availability 
of vaccines that also ensures that individuals in 
areas and locations where vulnerable populations 
often do not have easy access to health care or vac-
cinations are informed about vaccine availability; 
and 
(7) acting through the Department of Health 
and Human Services, provide additional vaccination 
centers, in addition to State and local government 
sites, to augment vaccinations occurring within such 
States and local governments to address access to 
at-risk communities when vaccination rates are 
below 80 percent for a population residing with in 
a census block or track that is experiencing a great-
er incidence of serious complications, such as hos-
pitalizations and deaths that are above the propor-
tional representation of the at-risk group when com-
pared to the general population, establishing the 
need for a targeted vaccination effort to reduce the 
incidence of infections for those individuals at great-
est risk for hospitalizations and death from COVID- 
19. 
VerDate Sep 11 2014 
22:06 Feb 06, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H330.IH
H330
kjohnson on DSK79L0C42PROD with BILLS
SEC. 3. CDC REQUIREMENTS. 
The Centers for Disease Control and Prevention shall 
track the dissemination of inoculations and report on effi-
ciencies, effectiveness, or deficiencies of local and State 
COVID-19 vaccination programs, including the avail-
ability of certified individuals under Federal, State, or ter-
ritorial authority to administer a vaccination under State 
law, and report to Congressional oversight committees in 
the House of Representatives and the Senate on findings 
and recommendations. 
SEC. 4. HHS MANAGEMENT OF COVID–19 VACCINATION 
DATA TO ACHIEVE MASS VACCINATION SATU-
RATION IMMUNITY. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall carry out a national program to oversee the 
collection and maintenance of all Federal and State data 
on vaccinations of individuals in the United States for 
COVID–19, including tracking booster vaccinations, to 
achieve mass vaccination saturation immunity. 
(b) APPLICABLE PRIVACY LAW; PENALTIES.— 
(1) IN GENERAL.—The Secretary shall main-
tain data on vaccinations for COVID–19 in accord-
ance with all applicable privacy and security law, in-
cluding HIPAA privacy and security law (as defined 
VerDate Sep 11 2014 
22:06 Feb 06, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H330.IH
H330
kjohnson on DSK79L0C42PROD with BILLS
in section 3009(a)(2) of the Public Health Service 
Act (42 U.S.C. 300jj–19(a)(2)). 
(2) PENALTIES.—Any person who discloses or 
uses data on vaccinations for COVID–19 in violation 
of any provision of law referred to in paragraph 
(1)— 
(A) shall be imprisoned for not more than 
5 years, or fined in accordance with title 18, or 
both; and 
(B) shall be subject, in addition to any 
other penalties that may be prescribed by law, 
to a civil money penalty of not more than 
$10,000 for each such violation. 
(c) DATA RETENTION LIMITATION.—The Secretary 
shall destroy any data maintained pursuant to subsection 
(a) by the end of the 5-year period beginning on the date 
of receipt or collection of the data, whichever is later. 
(d) TRANSMISSION OF STATE DATA.—The Secretary 
shall take such steps as may be necessary to encourage 
and assist each State in transmitting to the Secretary on 
an ongoing basis the State’s data with respect to vaccina-
tion of individuals in such State for COVID–19. 
(e) OMBUDSMAN.—The Secretary shall appoint an 
ombudsman to— 
VerDate Sep 11 2014 
22:06 Feb 06, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H330.IH
H330
kjohnson on DSK79L0C42PROD with BILLS
(1) support public and stakeholder input on the 
activities carried out pursuant to this section; 
(2) provide advocacy and advice for those who 
elect not to be vaccinated for COVID–19; and 
(3) champion the privacy and civil liberty rights 
of individuals in the United States in connection 
with vaccination for COVID–19. 
(f) COLLABORATION.—In carrying out this section, 
the Secretary shall collaborate with stakeholders in estab-
lishing vaccine inoculation centers in locations including— 
(1) stadiums, arenas, elementary and secondary 
schools, colleges and universities, and places of wor-
ship; and 
(2) other locations determined by the Secretary 
to be conducive to reaching the greatest number of 
people in need of inoculations for COVID–19. 
(g) ADVISORY BOARD.—For the purpose achieving 
mass vaccination saturation immunity to COVID–19 in 
the United States, the Secretary shall establish a stake-
holder advisory board to support the collaboration and co-
operation of entities including Federal, State, and local 
governments, businesses, colleges, universities, elementary 
and secondary schools, hospitals, clinics, professional med-
ical associations, and such other entities as the Secretary 
determines to be essential to such purpose. 
VerDate Sep 11 2014 
22:06 Feb 06, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H330.IH
H330
kjohnson on DSK79L0C42PROD with BILLS
(h) REPORTS.—On a daily or weekly basis, subject 
to subsection (b), the Secretary shall submit to the Con-
gress and make public reports on the activities carried out 
under this section, including such data as the Director of 
the Centers for Disease Control and Prevention deter-
mines to be relevant to analyzing inoculation statistics and 
progress toward achieving mass vaccination saturation im-
munity. 
Æ 
VerDate Sep 11 2014 
22:06 Feb 06, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H330.IH
H330
kjohnson on DSK79L0C42PROD with BILLS